Product image of Indapamida Krka (Indapamide) supplied by GNH India

Indapamida Krka

Active Ingredient:
Indapamide
Origin:
EU

Indapamida Krka (Indapamide)

Indapamide, the active ingredient in Indapamida Krka, is a thiazide‑like diuretic presented as a tablet (strength not specified) for oral use. It treats hypertension and helps reduce edema in patients with heart or renal disease.

GNH India supplies Indapamida Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Krka Farmacêutica, Unipessoal Lda.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Indapamide is a thiazide‑like diuretic used to manage conditions related to fluid overload and elevated blood pressure.

  • Hypertension: lowers systemic blood pressure and reduces cardiovascular risk.
  • Edema associated with heart failure: promotes fluid excretion to relieve swelling.
  • Edema associated with renal disease: enhances diuresis to decrease peripheral edema.

How It Works

  • Indapamide inhibits sodium‑chloride reabsorption in the distal convoluted tubule by blocking the Na+/Cl‑ cotransporter, leading to increased urinary excretion of sodium and water. The resulting reduction in plasma volume lowers peripheral vascular resistance, contributing to its antihypertensive effect while also decreasing fluid accumulation in edematous states.

Side Effects

Indapamide may cause a range of adverse reactions, from mild to serious.

Common Side Effects

  • Increased urination: more frequent need to void.
  • Electrolyte imbalance (low potassium): may cause muscle weakness.
  • Dizziness or light‑headedness: especially on standing.
  • Headache: mild to moderate intensity.
  • Fatigue: general feeling of tiredness.
  • Elevated blood glucose: may affect diabetic control.

Serious or Rare Side Effects

  • Severe dehydration: risk of hypotension and renal impairment.
  • Significant electrolyte disturbances (hypokalemia, hyponatremia): can lead to cardiac arrhythmias.
  • Gout attacks: increased uric acid levels.
  • Allergic reactions: rash, itching, or angioedema.
  • Blood dyscrasias: rare cases of leukopenia or thrombocytopenia.
  • Acute renal failure: especially in patients with pre‑existing kidney disease.

Precautions & Warnings

When prescribing Indapamide, clinicians should consider several safety measures.

  • Monitor electrolytes: regular blood tests to detect potassium or sodium changes.
  • Assess renal function: adjust therapy if creatinine clearance is reduced.
  • Evaluate blood pressure: avoid excessive hypotension, especially in the elderly.
  • Use caution in diabetes: monitor glucose as the drug may raise blood sugar.
  • Discontinue if hypersensitivity occurs: stop immediately upon signs of allergic reaction.
  • Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Indapamide interacts with several drug classes; some require avoidance while others need close monitoring.

Major Interactions (Avoid)

  • Lithium: increased lithium toxicity.
  • NSAIDs: reduced diuretic efficacy and possible renal impairment.
  • ACE inhibitors or ARBs: heightened risk of renal dysfunction and hyperkalemia.
  • Other thiazide diuretics: additive electrolyte loss.
  • Digoxin: enhanced digoxin toxicity due to electrolyte shifts.

Moderate Interactions (Monitor Closely)

  • Antihypertensives: additive blood‑pressure lowering effect.
  • Corticosteroids: increased potassium loss.
  • Antidiabetic agents: possible alteration of glucose control.
  • Calcium supplements or vitamin D: risk of hypercalcemia.
  • Alcohol: may exacerbate dizziness and hypotension.

Frequently Asked Questions

Indapamida Krka contains indapamide, a thiazide‑like diuretic indicated for the management of hypertension and for reducing edema associated with heart failure or renal disease. It helps lower blood pressure and promotes the removal of excess fluid from the body.

Indapamide blocks the sodium‑chloride cotransporter in the distal convoluted tubule of the kidney, reducing reabsorption of sodium and water. This leads to increased urine output, decreased plasma volume, and lowered peripheral vascular resistance, which together lower blood pressure and reduce fluid accumulation.

The appropriate dose of Indapamida Krka is determined by the prescribing healthcare professional based on the patient’s condition, age, kidney function, and response to therapy. Patients should follow the exact regimen provided by their prescriber and not adjust the dose on their own.

Safety of indapamide in pregnancy or lactation has not been definitively established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Indapamide belongs to the thiazide‑like diuretic class and offers a longer duration of action with a lower risk of certain metabolic side effects compared with traditional thiazides. It is often preferred when a sustained antihypertensive effect and effective edema control are needed, but the choice depends on individual patient factors.

Store Indapamida Krka at room temperature, below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Indapamida Krka is taken orally, usually with a glass of water. The tablet should be swallowed whole and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious risks include severe dehydration, significant electrolyte disturbances such as hypokalemia or hyponatremia, acute kidney injury, and rare allergic reactions. Patients should be monitored regularly for signs of these conditions, especially during the initial phases of therapy.

Indapamida Krka should be avoided in individuals with known hypersensitivity to indapamide or other sulfonamide drugs, in patients with severe renal impairment, and in those who are unable to maintain adequate fluid and electrolyte balance without close medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.